SHL Telemedicine Total Assets 2022-2023 | SHLT
SHL Telemedicine Annual Total Assets (Millions of US $) |
|
---|---|
2022 | $111 |
2021 | $130 |
SHL Telemedicine Quarterly Total Assets (Millions of US $) |
|
---|---|
2022-12-31 | $111 |
2021-12-31 | $130 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $0.068B | $0.057B |
SHL Telemedicine Ltd is engaged in developing and marketing personal telemedicine solutions, with a focus on cardiovascular and related diseases. Its solutions for healthcare professionals include: CHF monitoring service which supports patients suffering from Congestive Heart Failure; COPD monitoring service that supports patients suffering from Chronic Obstructive Pulmonary Disease and Readmission Solutions for reducing heart-related readmissions. SHL Telemedicine Ltd is based in Israel. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
GE HealthCare Technologies (GEHC) | United States | $36.275B | 19.92 |
Inspire Medical Systems (INSP) | United States | $7.566B | 0.00 |
Axonics (AXNX) | United States | $3.433B | 0.00 |
10x Genomics (TXG) | United States | $3.275B | 0.00 |
IRhythm Technologies (IRTC) | United States | $3.194B | 0.00 |
Azenta (AZTA) | United States | $2.979B | 242.82 |
Olink Holding AB (publ) (OLK) | Sweden | $2.861B | 0.00 |
Enovis (ENOV) | United States | $2.812B | 20.84 |
Hims & Hers Health (HIMS) | United States | $2.412B | 0.00 |
Privia Health (PRVA) | United States | $2.224B | 98.63 |
Schrodinger (SDGR) | United States | $1.712B | 0.00 |
Omnicell (OMCL) | United States | $1.384B | 47.83 |
Phreesia (PHR) | United States | $1.259B | 0.00 |
Definitive Healthcare (DH) | United States | $0.828B | 0.00 |
Standard BioTools (LAB) | United States | $0.728B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.643B | 0.00 |
Talkspace (TALK) | United States | $0.538B | 0.00 |
Health Catalyst (HCAT) | United States | $0.383B | 0.00 |
Pulmonx (LUNG) | United States | $0.378B | 0.00 |
Clover Health Investments (CLOV) | United States | $0.344B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.326B | 0.00 |
P3 Health Partners (PIII) | United States | $0.202B | 0.00 |
Butterfly Network (BFLY) | United States | $0.196B | 0.00 |
American Well (AMWL) | United States | $0.165B | 0.00 |
Outset Medical (OM) | United States | $0.162B | 0.00 |
Augmedix (AUGX) | United States | $0.133B | 0.00 |
MSP Recovery (LIFW) | United States | $0.125B | 0.00 |
TruBridge (TBRG) | United States | $0.125B | 5.33 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.108B | 0.00 |
111 (YI) | China | $0.096B | 0.00 |
Future Health ESG (FHLT) | United States | $0.071B | 0.00 |
HeartBeam (BEAT) | United States | $0.058B | 0.00 |
Zepp Health (ZEPP) | China | $0.053B | 0.00 |
Movano (MOVE) | United States | $0.046B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.044B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
Akili (AKLI) | United States | $0.032B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.024B | 0.00 |
Cue Health (HLTH) | United States | $0.022B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.019B | 0.00 |
CareCloud (CCLD) | United States | $0.018B | 0.00 |
ETAO (ETAO) | United States | $0.016B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.015B | 0.00 |
Biotricity (BTCY) | United States | $0.012B | 0.00 |
Transgenomic (PRPO) | United States | $0.009B | 0.00 |
Syra Health (SYRA) | United States | $0.008B | 0.00 |
Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
HeartSciences (HSCS) | United States | $0.006B | 0.00 |
Zhongchao (ZCMD) | China | $0.003B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
Centogene (CNTG) | Germany | $0.000B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |